SAGA Diagnostics
Pre-clinicalSAGA Diagnostics® is redefining the early detection of molecular residual disease (MRD), empowering treatment decisions with greater insight and confidence.
Founded
2016
Focus
Diagnostics
About
SAGA Diagnostics® is redefining the early detection of molecular residual disease (MRD), empowering treatment decisions with greater insight and confidence.
Funding History
3Total raised: $20M
Series B$12MScietyMar 15, 2022
Series A$6.5MIndustrifondenJun 15, 2020
Seed$1.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationLund, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile